Rachel Riley - Publications

Affiliations: 
2018- University of Pennsylvania, Philadelphia, PA, United States 

22 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Figueroa-Espada CG, Guimarães PPG, Riley RS, Xue L, Wang K, Mitchell MJ. siRNA Lipid-Polymer Nanoparticles Targeting E-Selectin and Cyclophilin A in Bone Marrow for Combination Multiple Myeloma Therapy. Cellular and Molecular Bioengineering. 16: 383-392. PMID 37810998 DOI: 10.1007/s12195-023-00774-y  0.501
2023 Guimarães PPG, Figueroa-Espada CG, Riley RS, Gong N, Xue L, Sewastianik T, Dennis PS, Loebel C, Chung A, Shepherd SJ, Haley RM, Hamilton AG, El-Mayta R, Wang K, Langer R, et al. In vivo bone marrow microenvironment siRNA delivery using lipid-polymer nanoparticles for multiple myeloma therapy. Proceedings of the National Academy of Sciences of the United States of America. 120: e2215711120. PMID 37310997 DOI: 10.1073/pnas.2215711120  0.747
2022 Young RE, Nelson KM, Hofbauer SI, Vijayakumar T, Alameh MG, Weissman D, Papachristou C, Gleghorn JP, Riley RS. Lipid Nanoparticle Composition Drives mRNA Delivery to the Placenta. Biorxiv : the Preprint Server For Biology. PMID 36597546 DOI: 10.1101/2022.12.22.521490  0.348
2021 Parhiz H, Brenner JS, Patel P, Papp TE, Shahnawaz H, Li Q, Shi R, Zamora M, Yadegari A, Marcos-Contreras OA, Natesan A, Pardi N, Shuvaev VV, Kiseleva R, Myerson J, ... ... Riley RS, et al. Added to pre-existing inflammation, mRNA-lipid nanoparticles induce inflammation exacerbation (IE). Journal of Controlled Release : Official Journal of the Controlled Release Society. PMID 34953981 DOI: 10.1016/j.jconrel.2021.12.027  0.473
2021 Riley RS, Kashyap MV, Billingsley MM, White B, Alameh MG, Bose SK, Zoltick PW, Li H, Zhang R, Cheng AY, Weissman D, Peranteau WH, Mitchell MJ. Ionizable lipid nanoparticles for in utero mRNA delivery. Science Advances. 7. PMID 33523869 DOI: 10.1126/sciadv.aba1028  0.772
2020 Figueroa-Espada CG, Mitchell MJ, Riley RS. Exploiting the placenta for nanoparticle-mediated drug delivery during pregnancy. Advanced Drug Delivery Reviews. PMID 32956719 DOI: 10.1016/J.Addr.2020.09.006  0.534
2020 Kashyap MV, Riley RS, Billingsley MM, White BM, Butt ZP, Mitchell MJ, Peranteau WH. Ionizable Lipid Nanoparticle Platforms for in Utero Drug Delivery Journal of the American College of Surgeons. 231: S204. DOI: 10.1016/J.JAMCOLLSURG.2020.07.757  0.736
2019 Guimaraes PP, Zhang R, Spektor R, Tan M, Chung A, Billingsley MM, El-Mayta R, Riley RS, Wang L, Wilson JM, Mitchell MJ. Ionizable lipid nanoparticles encapsulating barcoded mRNA for accelerated in vivo delivery screening. Journal of Controlled Release : Official Journal of the Controlled Release Society. PMID 31678653 DOI: 10.1016/J.Jconrel.2019.10.028  0.755
2019 Mukalel AJ, Riley RS, Zhang R, Mitchell MJ. Nanoparticles for Nucleic Acid Delivery: Applications in Cancer Immunotherapy. Cancer Letters. PMID 31100411 DOI: 10.1016/J.Canlet.2019.04.040  0.756
2019 Riley RS, June CH, Langer R, Mitchell MJ. Delivery technologies for cancer immunotherapy. Nature Reviews. Drug Discovery. PMID 30622344 DOI: 10.1038/S41573-018-0006-Z  0.615
2018 Valcourt DM, Harris J, Riley RS, Dang M, Wang J, Day ES. Advances in targeted nanotherapeutics: From bioconjugation to biomimicry. Nano Research. 11: 4999-5016. PMID 31772723 DOI: 10.1007/S12274-018-2083-Z  0.657
2018 Goyal R, Kapadia CH, Melamed JR, Riley RS, Day ES. Layer-by-layer assembled gold nanoshells for the intracellular delivery of miR-34a. Cellular and Molecular Bioengineering. 11: 383-396. PMID 30555597 DOI: 10.1007/S12195-018-0535-X  0.726
2018 Guimaraes PPG, Tan M, Tammela T, Wu K, Chung A, Oberli M, Wang K, Spektor R, Riley RS, Viana CTR, Jacks T, Langer R, Mitchell MJ. Potent in vivo lung cancer Wnt signaling inhibition via cyclodextrin-LGK974 inclusion complexes. Journal of Controlled Release : Official Journal of the Controlled Release Society. PMID 30290244 DOI: 10.1016/J.Jconrel.2018.09.025  0.52
2018 Riley RS, O'Sullivan RK, Potocny AM, Rosenthal J, Day ES. Evaluating Nanoshells and a Potent Biladiene Photosensitizer for Dual Photothermal and Photodynamic Therapy of Triple Negative Breast Cancer Cells. Nanomaterials (Basel, Switzerland). 8. PMID 30149630 DOI: 10.3390/Nano8090658  0.641
2018 Potocny AM, Riley RS, O'Sullivan RK, Day ES, Rosenthal J. Photochemotherapeutic Properties of a Linear Tetrapyrrole Palladium(II) Complex displaying an Exceptionally High Phototoxicity Index. Inorganic Chemistry. PMID 30132325 DOI: 10.1021/Acs.Inorgchem.8B01225  0.574
2018 Riley RS, Melamed JR, Day ES. Enzyme-Linked Immunosorbent Assay to Quantify Targeting Molecules on Nanoparticles. Methods in Molecular Biology (Clifton, N.J.). 1831: 145-157. PMID 30051430 DOI: 10.1007/978-1-4939-8661-3_11  0.781
2018 Riley RS, Dang MN, Billingsley MM, Abraham B, Gundlach L, Day ES. Evaluating the Mechanisms of Light-Triggered siRNA Release from Nanoshells for Temporal Control Over Gene Regulation. Nano Letters. PMID 29701993 DOI: 10.1021/Acs.Nanolett.8B00681  0.766
2017 Riley RS, Day ES. Frizzled7 Antibody-Functionalized Nanoshells Enable Multivalent Binding for Wnt Signaling Inhibition in Triple Negative Breast Cancer Cells. Small (Weinheim An Der Bergstrasse, Germany). PMID 28544579 DOI: 10.1002/Smll.201700544  0.639
2017 Billingsley MM, Riley RS, Day ES. Antibody-nanoparticle conjugates to enhance the sensitivity of ELISA-based detection methods. Plos One. 12: e0177592. PMID 28494030 DOI: 10.1371/Journal.Pone.0177592  0.756
2017 Melamed JR, Riley RS, Valcourt DM, Billingsley MM, Kreuzberger NL, Day ES. Quantification of siRNA Duplexes Bound to Gold Nanoparticle Surfaces. Methods in Molecular Biology (Clifton, N.J.). 1570: 1-15. PMID 28238126 DOI: 10.1007/978-1-4939-6840-4_1  0.744
2017 Riley RS, Day ES. Gold nanoparticle-mediated photothermal therapy: applications and opportunities for multimodal cancer treatment. Wiley Interdisciplinary Reviews. Nanomedicine and Nanobiotechnology. PMID 28160445 DOI: 10.1002/Wnan.1449  0.712
2016 Melamed JR, Riley RS, Valcourt DM, Day ES. Using Gold Nanoparticles To Disrupt the Tumor Microenvironment: An Emerging Therapeutic Strategy. Acs Nano. 10: 10631-10635. PMID 28024339 DOI: 10.1021/Acsnano.6B07673  0.785
Show low-probability matches.